Amrize Ltd (AMRZ)
Official siteBASIC MATERIALS • BUILDING MATERIALS • NYSE
Market Cap: $21.57B
Last updated: Nov 17, 2026 at 4:15 PM ET
Amrize Ltd (AMRZ) Statistics
Amrize (AMRZ) has a market cap of $21.57B and an enterprise value of $27.12B. Its trailing P/E is 17.2x.
Total Valuation
Enterprise value is 25.72% above the market cap, as debt exceeds cash.
| Market Cap | $21.57B |
|---|---|
| Enterprise Value | $27.12B |
| Latest price (Nov 17, 2026) | $39.82 |
Key Dates
The last ex-dividend date was Nov 10, 2026.
| Last Earnings Date | Oct 28, 2026 |
|---|---|
| Last Ex-Dividend Date | Nov 10, 2026 |
| Next Payment Date | Nov 18, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.8x and 1.7x.
| P/E Ratio | 17.2x |
|---|---|
| Forward P/E | 16.4x |
| P/S Ratio | 1.8x |
| Forward P/S | 1.7x |
| P/B Ratio | 1.7x |
| P/TBV Ratio | 10.6x |
| P/FCF Ratio | 20.0x |
| P/OCF Ratio | 10.6x |
| PEG Ratio | 1.4 |
Enterprise Valuation
Counting debt and cash, the company is valued at 9.4x EBITDA and 25.1x free cash flow.
| EV / Earnings | 22.3x |
|---|---|
| EV / Sales | 2.2x |
| EV / EBITDA | 9.4x |
| EV / EBIT | 14.2x |
| EV / FCF | 25.1x |
Price Statistics
The stock is down 17.64% over 52 weeks and trades 1.79% above its 50-day average.
| Beta (1Y) | 1.23 |
|---|---|
| 52-Week Change | -17.64% |
| 1-Month Change | +5.09% |
| 3-Month Change | -11.79% |
| 6-Month Change | -17.34% |
| Total Return (1Y) | -16.05% |
| Return vs SPY (1Y) | -27.09% |
| Max Drawdown (1Y) | -44.81% |
| Sharpe Ratio (1Y) | -0.45 |
| Correlation with SPY (1Y) | 0.45 |
| 50-Day Average | $39.12 |
| 200-Day Average | $49.55 |
| 52-Week Range | $35.69 to $64.97 |
| RSI (14 Days) | 46.1 |
| Average Volume (20 Days) | 4.47M |
Financial Position
Current assets cover 1.07x current liabilities, and total debt is 0.46x shareholder equity.
| Current Ratio | 1.07x |
|---|---|
| Quick Ratio | 0.67x |
| Debt / Equity | 0.46x |
| Debt / EBITDA | 2.02x |
| Debt / FCF | 5.40x |
Returns and Efficiency
Return on invested capital is 7.91% and return on equity is 9.62% over the last 12 months.
| Return on Equity (ROE) | 9.62% |
|---|---|
| Return on Assets (ROA) | 5.05% |
| Return on Invested Capital (ROIC) | 7.91% |
| Return on Capital Employed (ROCE) | 9.35% |
| Asset Turnover | 0.51x |
| Inventory Turnover | 5.90x |
| Receivables Turnover | 5.81x |
| Cash Conversion Cycle | 73 days |
Taxes
Income tax took 23.54% of pretax income over the last 12 months.
| Income Tax (TTM) | $372.00M |
|---|---|
| Effective Tax Rate | 23.54% |
Scores
AMRZ has an Altman Z-Score of 1.98, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.98 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $12.28B over the last 12 months is up 3.75% from the 12 months before.
| Revenue | $12.28B |
|---|---|
| Revenue Growth (YoY) | +3.75% |
| Gross Profit | $3.04B |
| Operating Income | $1.91B |
| Pretax Income | $1.58B |
| Net Income | $1.21B |
| EBITDA | $2.90B |
| EBIT | $1.91B |
| Reported EPS (TTM) | $2.31 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.42% of the $24.36B in total assets.
| Cash and Equivalents | $299.00M |
|---|---|
| Total Debt | $5.85B |
| Net Debt | $5.55B |
| Net Debt Per Share | $10.19 |
| Working Capital | $265.00M |
| Shareholder Equity | $12.77B |
| Book Value Per Share | $23.45 |
| Tangible Book Value | $2.05B |
| Tangible Book Per Share | $3.77 |
| Total Assets | $24.36B |
| Total Liabilities | $11.60B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $943.00M of capital spending, operating cash flow left $1.08B of free cash flow.
| Operating Cash Flow | $2.03B |
|---|---|
| Capital Expenditures | $943.00M |
| Free Cash Flow | $1.08B |
| FCF Per Share | $1.98 |
| Depreciation and Amortization | $1.00B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 15.55%, against a 5-year average of 16.55%.
| Gross Margin | 24.79% |
|---|---|
| Operating Margin | 15.55% |
| Pretax Margin | 12.86% |
| Net Margin | 9.88% |
| EBITDA Margin | 23.64% |
| EBIT Margin | 15.53% |
| FCF Margin | 8.82% |
| Gross Margin (5Y Average) | 24.21% |
| Operating Margin (5Y Average) | 16.55% |
| Net Margin (5Y Average) | 9.95% |
Growth
Revenue grew 3.28% a year over 3 years.
| Revenue Growth (3Y CAGR) | +3.28% |
|---|---|
| FCF Growth (3Y CAGR) | -1.81% |
| Operating Income Growth (3Y CAGR) | +3.91% |
| Book Value Per Share Growth (2Y CAGR) | +19.38% |
Dividends and Yields
AMRZ pays out 8.87% of earnings as dividends.
| Dividend Per Share (Annual) | $0.44 |
|---|---|
| Dividend Yield | 1.10% |
| Payout Ratio | 8.87% |
| Earnings Yield | 5.81% |
| FCF Yield | 4.99% |
| Buyback Yield | 2.64% |
Peer Position
Against 9 similar companies, AMRZ has the 6th highest P/E and the 5th highest ROIC.
P/E RatioPeer median 20.2x
P/S RatioPeer median 4.4x
ROICPeer median 6.08%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.40%
Dividend YieldPeer median 0.62%
| P/E Ratio | 17.2x vs 20.2x median |
|---|---|
| P/S Ratio | 1.8x vs 4.4x median |
| ROIC | 7.91% vs 6.08% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.75% vs +10.40% median |
| Dividend Yield | 1.10% vs 0.62% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AMRZ
What is AMRZ's market cap?
Amrize has a market cap of $21.57B. Its enterprise value, which adds debt and subtracts cash, is $27.12B.
What is AMRZ's P/E ratio?
Amrize has a trailing P/E ratio of 17.2x and a forward P/E of 16.4x.
How many shares of AMRZ are outstanding?
Amrize has 544.60M shares outstanding. The count is down 1.54% from a year earlier.
Does AMRZ pay a dividend?
Yes. Amrize pays $0.44 a share a year, a dividend yield of 1.10%.
How much debt does AMRZ have?
Amrize has $5.85B of total debt and $299.00M of cash and equivalents, a net debt position of $5.55B.
AMRZ pages: Overview, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts